These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 23167680

  • 1. From single-cell signature to prognostic factors: the case of Sézary syndrome.
    Scala E, Narducci MG, Russo G.
    Expert Rev Clin Immunol; 2012 Nov; 8(8):699-701. PubMed ID: 23167680
    [No Abstract] [Full Text] [Related]

  • 2. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
    Introcaso CE, Hess SD, Kamoun M, Ubriani R, Gelfand JM, Rook AH.
    J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
    [Abstract] [Full Text] [Related]

  • 3. CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.
    Benoit BM, Jariwala N, O'Connor G, Oetjen LK, Whelan TM, Werth A, Troxel AB, Sicard H, Zhu L, Miller C, Takeshita J, McVicar DW, Kim BS, Rook AH, Wysocka M.
    Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
    [Abstract] [Full Text] [Related]

  • 4. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, Tüting T.
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [Abstract] [Full Text] [Related]

  • 5. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E.
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [Abstract] [Full Text] [Related]

  • 6. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M, Almeida J, dos Anjos Teixeira M, Queiros ML, Santos AH, Fonseca S, Balanzategui A, Justica B, Orfao A.
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [Abstract] [Full Text] [Related]

  • 7. Management of cutaneous T-cell lymphoma: The future is here.
    Wood GS.
    J Am Acad Dermatol; 2001 Aug; 45(2):317. PubMed ID: 11464201
    [No Abstract] [Full Text] [Related]

  • 8. Expression of CD164 on Malignant T cells in Sézary Syndrome.
    Guenova E, Ignatova D, Chang YT, Contassot E, Mehra T, Saulite I, Navarini AA, Mitev V, Dummer R, Kazakov DV, French LE, Hoetzenecker W, Cozzio A.
    Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186
    [Abstract] [Full Text] [Related]

  • 9. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
    Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Steitz J, Roszkiewicz J, Bieber T, Tüting T.
    Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
    [Abstract] [Full Text] [Related]

  • 10. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC.
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [Abstract] [Full Text] [Related]

  • 11. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 12. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K, Löning T, Rehpenning W.
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [Abstract] [Full Text] [Related]

  • 13. Drug-induced pseudo-Sezary syndrome: a case report and literature review.
    Reeder MJ, Wood GS.
    Am J Dermatopathol; 2015 Jan; 37(1):83-6. PubMed ID: 25033012
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT, Novelli M, Quaglino P, Comessatti A, Fava P, Ortoncelli M, Ponti R, Bernengo MG.
    Dermatology; 2008 Jan; 216(3):213-21. PubMed ID: 18182812
    [Abstract] [Full Text] [Related]

  • 15. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
    Nagler AR, Samimi S, Schaffer A, Vittorio CC, Kim EJ, Rook AH.
    J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
    [Abstract] [Full Text] [Related]

  • 16. Expression of V beta gene segments by Sezary cells.
    Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F.
    J Invest Dermatol; 1995 Jul; 105(1):56-61. PubMed ID: 7542297
    [Abstract] [Full Text] [Related]

  • 17. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
    Fierro MT, Comessatti A, Quaglino P, Ortoncelli M, Osella Abate S, Ponti R, Novelli M, Bernengo MG.
    Dermatology; 2006 Jul; 213(4):284-92. PubMed ID: 17135733
    [Abstract] [Full Text] [Related]

  • 18. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK.
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [Abstract] [Full Text] [Related]

  • 19. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
    van der Fits L, Sandberg Y, Darzentas N, Zoutman WH, Tielemans D, Wolvers-Tettero IL, Vermeer MH, Langerak AW.
    Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672
    [Abstract] [Full Text] [Related]

  • 20. Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma.
    Miyagaki T, Sugaya M, Suga H, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.
    Acta Derm Venereol; 2013 Jul 06; 93(4):465-7. PubMed ID: 23306973
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.